<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Evry_Paris-Saclay_Improve skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Evry Paris-Saclay/Improve</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="container"> <DIV class="collapse navbar-collapse" id="navbarResponsive"><UL class="navbar-nav ml-auto"><LI class="nav-item"><A class="nav-link" href="https://2018.igem.org/Team:Evry_Paris-Saclay">Home</A></LI><LI class="nav-item dropdown"><A class="nav-link dropdown-toggle" href="https://2018.igem.org/Team:Evry_Paris-Saclay/Description" id="navbarDropdownProject" aria-haspopup="true" aria-expanded="false">
                Project
              </A><DIV class="dropdown-menu dropdown-menu-right" aria-labelledby="navbarDropdownProject"><A class="dropdown-item" href="https://2018.igem.org/Team:Evry_Paris-Saclay/Description">Description</A><A class="dropdown-item" href="https://2018.igem.org/Team:Evry_Paris-Saclay/Design">Design overview</A><A class="dropdown-item" href="https://2018.igem.org/Team:Evry_Paris-Saclay/Improve">The peptide</A><A class="dropdown-item" href="https://2018.igem.org/Team:Evry_Paris-Saclay/Model">The receptor</A><A class="dropdown-item" href="https://2018.igem.org/Team:Evry_Paris-Saclay/Demonstrate">The promoter</A><A class="dropdown-item" href="https://2018.igem.org/Team:Evry_Paris-Saclay/Futur_perspective">Future perspectives</A><SPAN class="separationMenu">--------------</SPAN><A class="dropdown-item" href="https://2018.igem.org/Team:Evry_Paris-Saclay/InterLab">Interlab</A><SPAN class="separationMenu">--------------</SPAN><A class="dropdown-item" href="https://2018.igem.org/Team:Evry_Paris-Saclay/Notebook">Notebook</A></DIV></LI><LI class="nav-item dropdown"><A class="nav-link dropdown-toggle" href="https://2018.igem.org/Team:Evry_Paris-Saclay/Parts" id="navbarDropdownParts" aria-haspopup="true" aria-expanded="false">
                Parts
              </A><DIV class="dropdown-menu dropdown-menu-right" aria-labelledby="navbarDropdownParts"><A class="dropdown-item" href="https://2018.igem.org/Team:Evry_Paris-Saclay/Parts#basic_parts">Basic Parts</A><A class="dropdown-item" href="https://2018.igem.org/Team:Evry_Paris-Saclay/Parts#composite_parts">Composite Parts</A><A class="dropdown-item" href="https://2018.igem.org/Team:Evry_Paris-Saclay/Parts#part_collection">Part Collection</A></DIV></LI><LI class="nav-item dropdown"><A class="nav-link dropdown-toggle" href="https://2018.igem.org/Team:Evry_Paris-Saclay/Human_Practices" id="navbarDropdownHumanPractices" aria-haspopup="true" aria-expanded="false">
                Human Practices
              </A><DIV class="dropdown-menu dropdown-menu-right" aria-labelledby="navbarDropdownHumanPractices"><A class="dropdown-item" href="https://2018.igem.org/Team:Evry_Paris-Saclay/Human_Practices#overview">Overview</A><A class="dropdown-item" href="https://2018.igem.org/Team:Evry_Paris-Saclay/Human_Practices#meeting_professionals">Meeting with professionals</A><A class="dropdown-item" href="https://2018.igem.org/Team:Evry_Paris-Saclay/Human_Practices#applications">Applications</A><A class="dropdown-item" href="https://2018.igem.org/Team:Evry_Paris-Saclay/Public_Engagement">Education &amp; public engagement</A><A class="dropdown-item" href="https://2018.igem.org/Team:Evry_Paris-Saclay/Human_Practices#integrated_human_practices">Integrated human practices</A><A class="dropdown-item" href="https://2018.igem.org/Team:Evry_Paris-Saclay/Collaborations">Collaborations</A></DIV></LI><LI class="nav-item"><A class="nav-link" href="https://2018.igem.org/Team:Evry_Paris-Saclay/Achievement">Achievement</A></LI><LI class="nav-item dropdown"><A class="nav-link dropdown-toggle" href="https://2018.igem.org/Team:Evry_Paris-Saclay/Team" id="navbarDropdownTeam" aria-haspopup="true" aria-expanded="false">
                Team
              </A><DIV class="dropdown-menu dropdown-menu-right" aria-labelledby="navbarDropdownTeam"><A class="dropdown-item" href="https://2018.igem.org/Team:Evry_Paris-Saclay/Team">Team Members</A><A class="dropdown-item" href="https://2018.igem.org/Team:Evry_Paris-Saclay/Attributions">Attributions</A><A class="dropdown-item" href="https://2018.igem.org/Team:Evry_Paris-Saclay/Sponsors">Sponsors</A></DIV></LI></UL></DIV></DIV><DIV class="container"><DIV class="col-md-3" style="width:auto;"><P style="color: white; text-align:left;" class="bibliographie"><B font-weight:900="">TO CONTACT US</B> Genopole Campus 1, Batiment 6, 91030 Evry Cedex, France +33 7 69 96 68 31<A href="mailto:igemevry@gmail.com"> igemevry@gmail.com</A></P></DIV><DIV class="col-md-3" style="width:auto;"><P style="color: white; text-align:left;" class="bibliographie">© Copyright 2018Design &amp; Developpement byIGEM EVRY GENOPOLE</P></DIV></DIV><DIV class="contentEvry" style="text-align:center; padding-left:auto; padding-right:auto;"><H1 style="font-weight:800; text-align:center;">THE PEPTIDE</H1><P style="font-size:15px;">In our system, the hexapeptide SAIRGA is the signalling molecule used for cell-to-cell communication [1]. To perform its quorum sensing function in the natural phi3T phage infection, SAIRGA needs to be secreted out of the cell. It is produced as an immature pre-pro-peptide, AimP (<A href="http://parts.igem.org/Part:BBa_K2279001" target="__blank">BBa_K2279001</A>), that upon secretion is cleaved extracellularly to remove the secretion signal and release the mature hexapeptide. The mature peptide then re-enters cells and binds to its receptor protein AimR (<A href="http://parts.igem.org/Part:BBa_K2279000" target="__blank">BBa_K2279000</A>). Binding of SAIRGA to AimR blocks the activator function of AimR that, in turn, facilitates a switch from lytic-to-lysogenic viral cycle. By acting as a negative regulator of AimR, the SAIRGA signal makes the lysis-to-lysogeny switch of phi3T phage dependent on the “quorum” of phi3T phages in the bacterial population.</P><H2 style="font-weight:800; text-align:center;">DESIGN</H2><P style="font-size:15px;">In phi3T phage, SAIRGA is produced as AimP (<A href="http://parts.igem.org/Part:BBa_K2279001" target="__blank">BBa_K2279001</A>) with specific secretion and protease-cleavage tags [1] that allow secretion and extracellular processing by <EM>Bacillus</EM>. Since we had no further information about this protease, we could not investigate the ability of <EM>Escherichia coli</EM> to produce a similar enzyme. Consequently, to produce SAIRGA in <EM>E. coli</EM>, we decided to replace this tag by an <EM>E. coli</EM> secretion signal. We have investigated three different secretion signals: OmpA (<A href="http://parts.igem.org/Part:BBa_K208003" target="__blank">BBa_K208003</A>), PelB (<A href="http://parts.igem.org/Part:BBa_J32015" target="__blank">BBa_J32015</A>) and Tat of <EM>csp2</EM> gene of <EM>Corynebacterium glutamicum</EM> (Uniprot Q04985).</P><P style="font-size:15px;">
To express them in <EM>E. coli</EM>, we codon optimized all sequences for <EM>E. coli</EM> DH5α, designed specific RBSs with the Salis Lab RBS Calculator [2, 3] and placed these peptides under the control of the constitutive strong promoter <A href="http://parts.igem.org/Part:BBa_J23100" target="__blank">BBa_J23100</A>. Thus, we generated four SAIRGA expression plasmids (<A href="http://parts.igem.org/Part:BBa_K2675041" target="__blank">BBa_K2675041</A>, <A href="http://parts.igem.org/Part:BBa_K2675042" target="__blank">BBa_K2675042</A>, <A href="http://parts.igem.org/Part:BBa_K2675043" target="__blank">BBa_K2675043</A> and <A href="http://parts.igem.org/Part:BBa_K2675044" target="__blank">BBa_K2675044</A>).</P><TABLE><TBODY><TR><TH style="text-align:center;">Part Name</TH><TH style="text-align:center;">Translated CDS Sequence</TH><TH style="text-align:center;">Part Number</TH><TH style="text-align:center;">Expression Cassette Part Number</TH></TR><TR><TD>AimP</TD><TD>MKKVFFGLVILTALAISFVAGQQSVSTASASDEVTVA<FONT style="color:#FF0000;">SAIRGA</FONT></TD><TD><A href="http://parts.igem.org/Part:BBa_K2675001" target="__blank">BBa_K2675001</A></TD><TD><A href="http://parts.igem.org/Part:BBa_K2675041" target="__blank">BBa_K2675041</A></TD></TR><TR><TD>OmpA-SAIRGA</TD><TD>MKKTAIAIAVALAGFATVAQA<FONT style="color:#FF0000;">SAIRGA</FONT></TD><TD><A href="http://parts.igem.org/Part:BBa_K2675002" target="__blank">BBa_K2675002</A></TD><TD><A href="http://parts.igem.org/Part:BBa_K2675042" target="__blank">BBa_K2675042</A></TD></TR><TR><TD>PelB-SAIRGA</TD><TD>MKYLLPTAAAGLLLLAAQPAMA<FONT style="color:#FF0000;">SAIRGA</FONT></TD><TD><A href="http://parts.igem.org/Part:BBa_K2675003" target="__blank">BBa_K2675003</A></TD><TD><A href="http://parts.igem.org/Part:BBa_K2675043" target="__blank">BBa_K2675043</A></TD></TR><TR><TD>Tat-SAIRGA</TD><TD>MFNNRIRTAALAGAIAISTAASGVAIPAFA<FONT style="color:#FF0000;">SAIRGA</FONT></TD><TD><A href="http://parts.igem.org/Part:BBa_K2675004" target="__blank">BBa_K2675004</A></TD><TD><A href="http://parts.igem.org/Part:BBa_K2675044" target="__blank">BBa_K2675044</A></TD></TR></TBODY></TABLE><H2 style="font-weight:800; text-align:center;">EXPERIMENTAL SETUP</H2><P style="font-size:15px;"><EM>E. coli</EM> DH5α harboring the SAIRGA expression plasmids were grown at 37°C in mineral salts medium [4] containing 2 mg/mL glucose and 35 μg/mL chloramphenicol (Figure 8). During the culturing, samples were prelevated, centrifuged and the supernatant was first sterilised by filtering through a 0.22 µm membrane, then loaded on a Pall Nanosep centrifugal device with Omega membrane (MWCO 3 kDa). The low molecular weight fraction of the culturing media thus recovered was analysed by LC-MS: ultra high pressure liquid column chromatography (UPLC) on a ACQUITY HSS T3  1.8 µM, 2.1 x 100 mm column (Waters) coupled with a Xevo G2-S Qtof mass spectrometer (Waters). The chromatography was performed using a gradient of using a (A) 1% formic acid in whater / (B) 1% formic acid in acetonitrile with the following program: from 0 to 5 min solvent B was increased from 2% to 70%, then it was maintained for 1 min at 70%; aftrewards it was decreased in 30 sec to 2% and it was maintained at 2% for 3.5 min for column re-equilibration. The flow rate was 0.2 mL/min and the column temperature was set to 45°C. The ions were detected in resolution negative mode.</P><P style="font-size:15px;">The pure synthetic SAIRGA peptide was readily detected by LC-MS. As shown in Figures 1 and 2, a peak of 572 Da, which correspond to SAIRGA’s monoisotopic mass [M-H]- was observed at a retention time of 3.9 min (Figure 3). The area under the curve is proportional to the concentration of SAIRGA (Figure 4).</P><FIGURE><FIGCAPTION style="font-size:12px;font-family: 'Nunito', sans-serif;"><B>Figure 1</B>: Mass spectrometry analysis of SAIRGA’s fraction obtained with various amounts of pure synthetic SAIRGA peptide.</FIGCAPTION></FIGURE><FIGURE><FIGCAPTION style="font-size:12px;font-family: 'Nunito', sans-serif;"><B>Figure 2</B>: Mass spectrometry analysis of SAIRGA’s fraction obtained with 5 µM of pure synthetic SAIRGA peptide (zoom on SAIRGA’s peak).</FIGCAPTION></FIGURE><FIGURE><FIGCAPTION style="font-size:12px;font-family: 'Nunito', sans-serif;"><B>Figure 3</B>: UPLC chromatograms obtained with various amount of pure synthetic SAIRGA peptide. </FIGCAPTION></FIGURE><FIGURE><FIGCAPTION style="font-size:12px;font-family: 'Nunito', sans-serif;"><B>Figure 4</B>: Standard curve of the area under the curve obtained by UPLC as a function of the concentration of SAIRGA.</FIGCAPTION></FIGURE><H2 style="font-weight:800; text-align:center;">RESULTS</H2><P style="font-size:15px;">LC-MS analysis of samples isolated from the fermentation broth of the <EM>E. coli</EM> strains harbouring a SAIRGA expression plasmid was performed.</P><P style="font-size:15px;">As shown in Figures 5 and 6, the expression vector of OmpA-SAIRGA (<A href="http://parts.igem.org/Part:BBa_K2675042" target="__blank">BBa_K2675042</A>) is able to produce a compound with a monoisotopic mass a peak of 572 Da, which correspond to SAIRGA’s monoisotopic mass [M-H]- at a retention time of 3.9 min. The size or the area under the peak is increasing with time (figure 7). This suggests that OmpA is an efficient <EM>E. coli</EM> secretion tag which allows the release of the mature peptide SAIRGA in the culturing media.</P><FIGURE><FIGCAPTION style="font-size:12px;font-family: 'Nunito', sans-serif;"><B>Figure 5</B>: Mass spectrometry of culturing media taken after 2, 4, 6 and 8 hours of incubation of <EM>E. coli</EM> cells harboring the OmpA-SAIRGA expression cassette in pSB1C3 (<A href="http://parts.igem.org/Part:BBa_K2675042" target="__blank">BBa_K2675042</A>). The negative control has been performed with an empty pSB1C3 (bottom red chromatogram). The positive control (pure synthetic SAIRGA at 5 µM) is represented as the top red chromatogram.</FIGCAPTION></FIGURE><FIGURE><FIGCAPTION style="font-size:12px;font-family: 'Nunito', sans-serif;"><B>Figure 6</B>: UPLC chromatograms of culturing media taken after 2, 4, 6 and 8 hours of incubation of <EM>E. coli</EM> cells harboring the OmpA-SAIRGA expression cassette in pSB1C3 (<A href="http://parts.igem.org/Part:BBa_K2675042" target="__blank">BBa_K2675042</A>). The negative control has been performed with an empty pSB1C3 (bottom green chromatogram). The positive control (pure synthetic SAIRGA at 5 µM) is represented as the top red chromatogram.</FIGCAPTION></FIGURE><FIGURE><FIGCAPTION style="font-size:12px;font-family: 'Nunito', sans-serif;"><B>Figure 7</B>: SAIRGA production at 37°C by <EM>E. coli</EM> cells harboring the various SAIRGA expression plasmids (<A href="http://parts.igem.org/Part:BBa_K2675041" target="__blank">BBa_K2675041</A>, <A href="http://parts.igem.org/Part:BBa_K2675042" target="__blank">BBa_K2675042</A>, <A href="http://parts.igem.org/Part:BBa_K2675043" target="__blank">BBa_K2675043</A> and <A href="http://parts.igem.org/Part:BBa_K2675044" target="__blank">BBa_K2675044</A>). The negative control has been performed with an empty pSB1C3.</FIGCAPTION></FIGURE><FIGURE><FIGCAPTION style="font-size:12px;font-family: 'Nunito', sans-serif;"><B>Figure 8</B>: Growth curves at 37°C of <EM>E. coli</EM> cells harboring the various SAIRGA expression plasmids (<A href="http://parts.igem.org/Part:BBa_K2675041" target="__blank">BBa_K2675041</A>, <A href="http://parts.igem.org/Part:BBa_K2675042" target="__blank">BBa_K2675042</A>, <A href="http://parts.igem.org/Part:BBa_K2675043" target="__blank">BBa_K2675043</A> and <A href="http://parts.igem.org/Part:BBa_K2675044" target="__blank">BBa_K2675044</A>). The negative control has been performed with an empty pSB1C3.</FIGCAPTION></FIGURE><P style="font-size:15px;">
The other parts (<A href="http://parts.igem.org/Part:BBa_K2675041" target="__blank">BBa_K2675041</A>, <A href="http://parts.igem.org/Part:BBa_K2675043" target="__blank">BBa_K2675043</A> and <A href="http://parts.igem.org/Part:BBa_K2675044" target="__blank">BBa_K2675044</A>) did not show any peak at 572 Da, which suggests that the native <EM>Bacillus</EM> secretion tag, as well as PelB and Tat signals are not able to secrete the mature peptide. We suspect that, in each case, the pro-peptide is produced and released but its secretion tag is not cleaved by the cell.</P><P style="font-size:15px;">Moreover, after 24h of incubation, we were unable to detect the SAIRGA peptide in the culturing media (Figures 9 and 10). This is probably due to the exhaustion of the medium: and the instability of the secreted peptide in the medium.</P><FIGURE><FIGCAPTION style="font-size:12px;font-family: 'Nunito', sans-serif;"><B>Figure 9</B>: UPLC chromatogram obtained with media taken after 24h of incubation of <EM>E. coli</EM> cells harboring the OmpA-SAIRGA expression cassette in pSB1C3 (<A href="http://parts.igem.org/Part:BBa_K2675042" target="__blank">BBa_K2675042</A>).
</FIGCAPTION></FIGURE><FIGURE><FIGCAPTION style="font-size:12px;font-family: 'Nunito', sans-serif;"><B>Figure 10</B>: Mass spectrometry analysis of the media taken after 24h of incubation of <EM>E. coli</EM> cells harboring the OmpA-SAIRGA expression cassette in pSB1C3 (<A href="http://parts.igem.org/Part:BBa_K2675042" target="__blank">BBa_K2675042</A>).
</FIGCAPTION></FIGURE><H2 style="font-weight:800; text-align:center;">CONCLUSION</H2><P style="font-size:15px;">We have successfully built a part, OmpA-SAIRGA (<A href="http://parts.igem.org/Part:BBa_K2675002" target="__blank">BBa_K2675002</A>), which is able to produce and release the mature hexapeptide SAIRGA in the culturing media of <EM>E. coli</EM> cells harboring this part equipped with an RBS and under the control of a constitutive promoter (<A href="http://parts.igem.org/Part:BBa_K2675042" target="__blank">BBa_K2675042</A>).</P><P style="font-size:15px;">Thus, we have made an improvement of the <A href="http://parts.igem.org/Part:BBa_K2279001" target="__blank">BBa_K2279001</A>, the SAIRGA peptide with the original secretion signal, that is not functional in <EM>E. coli</EM> under un equivalent transcriptional and translational control (<A href="http://parts.igem.org/Part:BBa_K2675041" target="__blank">BBa_K2675041</A>).

</P><H2 style="font-weight:800; text-align:center;">REFERENCES</H2><P style="font-size:15px;" class="bibliographie">[1] Erez Z, Steinberger-Levy I, Shamir M, Doron S, Stokar-Avihail A, Peleg Y, Melamed S, Leavitt A, Savidor A, Albeck S, Amitai G, Sorek R. Communication between viruses guides lysis-lysogeny decisions. Nature (2017) 541, 488-493.</P><P style="font-size:15px;" class="bibliographie">[2] Espah Borujeni A, Channarasappa AS, Salis HM. Translation rate is controlled by coupled trade-offs between site accessibility, selective RNA unfolding and sliding at upstream standby sites. Nucleic Acids Res (2014) 42, 2646-2659.</P><P style="font-size:15px;" class="bibliographie">[3] Salis HM, Mirsky EA, Voigt CA. Automated design of synthetic ribosome binding sites to control protein expression. Nat Biotechnol (2009) 27, 946-50.</P><P style="font-size:15px;" class="bibliographie">[4] Hall BG. Activation of the bgl operon by adaptive mutation. Mol Biol Evol (1998) 15, 1-5.</P></DIV><DIV class="container"><DIV class="row"><TABLE class="direction" style="border: none; width:80%;"><TBODY><TR><TH><A href="https://2018.igem.org/Team:Evry_Paris-Saclay/Design" style="color:black;">Previous</A></TH><TH><A href="https://2018.igem.org/Team:Evry_Paris-Saclay/Model" style="color:black;">Next</A></TH></TR></TBODY></TABLE></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>